Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cottle

Showing results (341-350 of 363) with videos related to

Pageof 37
Sort By:
The Journal of Clinical Investigation|February 16, 2008
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathyJoachim Schessl, Yaqun Zou, Meagan J McGrath, et al.
The Lancet. HIV|June 5, 2020
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trialRaphael J Landovitz, Sue Li, Joseph J Eron, et al.
Nature|June 17, 2005
'Magic' nucleus 42SiJ Fridmann, I Wiedenhöver, A Gade, et al.
Physical Review Letters|February 18, 2017
Isomeric Character of the Lowest Observed 4^{+} State in ^{44}SJ J Parker, I Wiedenhöver, P D Cottle, et al.
Plos One|June 20, 2024
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret modelDouglas S Reed, Anita K McElroy, Dominique J Barbeau, et al.
Plos Medicine|November 9, 2018
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trialRaphael J Landovitz, Sue Li, Beatriz Grinsztejn, et al.
Cell|August 20, 2021
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitopeArthur S Kim, Natasha M Kafai, Emma S Winkler, et al.
Conflict and Health|November 7, 2024
Integrating mental health and psychosocial support into economic inclusion programming for displaced families in EcuadorArianna Moyano, Daniela Vergara, Amaleah Mirti, et al.
AIDS and Behavior|June 10, 2022
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)Kenneth H Mayer, Krista Yuhas, K Rivet Amico, et al.
Plos Pathogens|September 18, 2020
SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tractsAmy L Hartman, Sham Nambulli, Cynthia M McMillen, et al.
Pageof 37

Showing results (341-350 of 363) with videos related to

Sort By:
Pageof 37
The Journal of Clinical Investigation|February 16, 2008
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathyJoachim Schessl, Yaqun Zou, Meagan J McGrath, et al.
The Lancet. HIV|June 5, 2020
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trialRaphael J Landovitz, Sue Li, Joseph J Eron, et al.
Nature|June 17, 2005
'Magic' nucleus 42SiJ Fridmann, I Wiedenhöver, A Gade, et al.
Physical Review Letters|February 18, 2017
Isomeric Character of the Lowest Observed 4^{+} State in ^{44}SJ J Parker, I Wiedenhöver, P D Cottle, et al.
Plos One|June 20, 2024
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret modelDouglas S Reed, Anita K McElroy, Dominique J Barbeau, et al.
Plos Medicine|November 9, 2018
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trialRaphael J Landovitz, Sue Li, Beatriz Grinsztejn, et al.
Cell|August 20, 2021
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitopeArthur S Kim, Natasha M Kafai, Emma S Winkler, et al.
Conflict and Health|November 7, 2024
Integrating mental health and psychosocial support into economic inclusion programming for displaced families in EcuadorArianna Moyano, Daniela Vergara, Amaleah Mirti, et al.
AIDS and Behavior|June 10, 2022
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)Kenneth H Mayer, Krista Yuhas, K Rivet Amico, et al.
Plos Pathogens|September 18, 2020
SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tractsAmy L Hartman, Sham Nambulli, Cynthia M McMillen, et al.
Pageof 37